Table 5.
Prevalence and persistence of HPV types detected at baseline and follow up
| HPV type | Baseline | Follow up | % Persistence |
| HR-HPV type | |||
| 16 | 33 | 16 | 48.5 |
| 18 | 10 | 2 | 20.0 |
| 31 | 10 | 1 | 10.0 |
| 33 | 5 | 3 | 60.0 |
| 35 | 1 | 0 | 0 |
| 39 | 1 | 0 | 0 |
| 45 | 7 | 1 | 14.3 |
| 51 | 12 | 0 | 0 |
| 52 | 6 | 1 | 16.7 |
| 53 | 9 | 1 | 11.1 |
| 56 | 7 | 2 | 28.6 |
| 58 | 6 | 2 | 33.3 |
| 59 | 7 | 4 | 57.1 |
| 66 | 9 | 1 | 11.1 |
| 68 | 2 | 0 | 0 |
| 73 | 7 | 0 | 0 |
| 82 | 1 | 0 | 0 |
| Total HR-HPV | 133 | 34 | 25.6% |
| LR-HPV type | |||
| 6 | 5 | 0 | 0 |
| 11 | 2 | 0 | 0 |
| 40 | 2 | 0 | 0 |
| 42 | 9 | 2 | 22.2 |
| 54 | 2 | 0 | 0 |
| 55 | 2 | 1 | 50.0 |
| 57 | 1 | 0 | 0 |
| 83 | 1 | 0 | 0 |
| 84 | 3 | 0 | 0 |
| Total LR-HPV | 27 | 3 | 11.1% |
Human papillomavirus (HPV) types within mixed infections are described separately. The table is subdivided into high risk (HR) and low risk (LR) HPV types and their totals are calculated.